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Abstract
Background: Internal Ribosome Entry Site (IRES)-based bicistronic vectors are important tools
in today's cell biology. Among applications, the expression of two proteins under the control of a
unique promoter permits the monitoring of expression of a protein whose biological function is
being investigated through the observation of an easily detectable tracer, such as Green
Fluorescent Protein (GFP). However, analysis of published results making use of bicistronic vectors
indicates that the efficiency of the IRES-controlled expression can vary widely from one vector to
another, despite their apparent identical IRES sequences. We investigated the molecular basis for
these discrepancies.
Results: We observed up to a 10 fold difference in IRES-controlled expression from distinct
bicistronic expression vectors harboring the same apparent IRES sequences. We show that the
insertion of a HindIII site, in place of the initiating AUG codon of the wild type EMCV IRES, is
responsible for the dramatic loss of expression from the second cistron, whereas expression from
the first cistron remains unaffected. Thus, while the replacement of the authentic viral initiating
AUG by a HindIII site results in the theoretical usage of the initiation codon of the HindIII-
subcloned cDNA, the subsequent drop of expression dramatically diminishes the interest of the
bicistronic structure. Indeed, insertion of the HindIII site has such a negative effect on IRES function
that detection of the IRES-controlled product can be difficult, and sometimes even below the levels
of detection. It is striking to observe that this deleterious modification is widely found in available
IRES-containing vectors, including commercial ones, despite early reports in the literature stating
the importance of the integrity of the initiation codon for optimal IRES function.
Conclusion: From these observations, we engineered a new vector family, pPRIG, which respects
the EMCV IRES structure, and permits easy cloning, tagging, sequencing, and expression of any
cDNA in the first cistron, while keeping a high level of expression from its IRES-dependent second
cistron (here encoding eGFP).
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Background
Expressing two distinct coding sequences under the con-
trol of a unique promoter is of great interest to molecular
and cellular biologists. Since both proteins are under the
control of the same promoter, detection of the product
encoded by the second cistron is the insurance that the
first cistron is also being expressed. One can take advan-
tage of bicistronic expression to select clones based on a
resistance encoded by the second cistron [1], as well as
sorting cells upon their GFP expression status. Polycis-
tronic expression is also of potentially great interest when
simultaneous expression of two different proteins is
required for development of new gene therapy
approaches [2]. Several commercially available bicistronic
vectors are based on the Internal Ribosome Entry Site
(IRES) from the Encephalomyocarditis virus (EMCV), in
which the AUG has been modified to a HindIII site. This
modification facilitates the cloning of the IRES-controlled
cDNA, and insures that the initiation codon stems from
the coding sequence inserted downstream of this cloning
site. This avoids the N-terminal addition of amino acids
derived from the junction of the IRES to the coding
sequence of interest. However, previously published
observations [3,4] demonstrated that this AUG is actually
the most efficiently recognized by the translation machin-
ery in the EMCV IRES. We compared the expression of a
full-length cDNA cloned either in the HindIII-modified
EMCV IRES (the ATG initiation codon being that of the
cDNA), or downstream of the original unmodified EMCV
initiation codon (which is then used as the initiation
codon). We observed that expression of the second cistron
in the HindIII-modified vectors can be as much as 10 fold
lower than the expression of the same cistron whose trans-
lation initiates at the original, non-modified EMCV initi-
ation codon.
In view of this dramatic decrease of IRES activity, we
developed a new and convenient set of eukaryotic bicis-
tronic expression vectors that respects the original EMCV
initiation environment and fulfills several important
needs: ease of cloning, sequencing possibilities of the
cloned inserts using universal primers, high level of plas-
mid DNA production, possibility of epitope tagging for
immunological tracking of expressed inserts, possibility of
production of retroviral particles for retroviral transduc-
tion, and easy monitoring of expression through the con-
comitant synthesis of a fluorescent protein (GFP).
Results
Selection of an optimal IRES sequence
We observed that the expression of coding sequences
derived from the second cistron of bicistronic vectors built
on the IRES derived from the EMCV genome varied widely
depending upon the vectors used. Specifically, the inten-
sity of fluorescence driven by the second cistron of the
pAP2 vector [5] was consistently much weaker than the
intensity of fluorescence driven by the second cistron of
the pMigR vector [6], despite the fact that both utilize the
EMCV-derived IRES. We sequenced the IRES from both
vectors and observed that the ATG codon that had been
previously shown to be used as the initiating codon in
EMCV [3], has been modified to a HindIII site in the pAP2
vector, while remaining untouched in the pMigR vector
(This AUG is at position 860 in the 7861 bp EMCV
sequence deposited in Genbank under the accession
X74312, see Table 1). In order to test the possibility that
this change could be responsible for the low eGFP expres-
sion level seen in pAP2, we engineered pMigR-derived
vectors identical in sequences, except for the EMCV IRES
initiation codon flanking region: pMigR-ATG contains the
wild type IRES sequence, while pMigR-Hd contains the
Table 1







Top: Comparison of sequences flanking the initiation codon in high (Wild type IRES) and low (HindIII-modified IRES) IRES activity bicistronic 
vectors.
Bold font represent the original ATG EMCV IRES initiation codon, and the corresponding modified HindIII site. Italic font is part of the NcoI site 
(position 870 in the EMCV sequence) that can be used to clone the cDNA of interest under IRES control.
Bottom: FACS analysis of GFP expression of the different vectors.
HEK 293T cells were transfected with the indicated constructs, and subjected to FACS analysis 2 days post-transfection. The percentages of 
detected GFP positive cells are indicated, as well as the peak value of the GFP signals.
8 6 0     8 7 0  
  |        |  
Wild Type IRES : CCTTTGAAAAACACGATGATAATATGGCCACAACCATGG
HindIII-modified IRES : CCTTTGAAAAACACGATGATAAGCTTGCCACAACCATGG
BMC Biotechnology 2006, 6:4 http://www.biomedcentral.com/1472-6750/6/4
Page 3 of 9
(page number not for citation purposes)
HindIII modified EMCV IRES. We inserted the eGFP cod-
ing sequence with its own ATG downstream of these
IRESes, so that the fluorescence directly reflects the IRES
activity.
293T cells were transfected with the same amount of the
different vector DNAs, and were subsequently subjected
to FACS analysis. As indicated in Table 1, fluorescence
intensity was reproducibly much weaker from the Hin-
dIII-modified IRES (pMigR-Hd) compared to the expres-
sion from its wild type counterpart (pMigR-ATG) or the
original pMigR, despite that in both cases their transcrip-
tion originated from the same LTR promoters. The Hin-
dIII-modification of the EMCV IRES Initiation codon, in
agreement with early reports on its structure and function
[3], is thus responsible for an over 10 fold decrease in
expression (14 versus 234 peak values). A similar analysis,
performed with the same vectors containing an additional
cDNA cloned into the first cistron (pMigR-Hd-BAZF and
pMigR-ATG-BAZF), gave very similar results (Table 1).
This confirms that the difference in the efficiency of
expression of the second cistron is solely the result of dif-
ferences in the IRES AUG initiation codon flanking
sequences. The proportion of GFP positive cells is compa-
rable in all cases, indicating that the strong difference of
peak values is not due to differences in transfection effi-
ciency.
To rule out that the differences in fluorescence intensities
would result from differences in promoter activities rather
than from a decrease in the expression of the IRES-con-
trolled fluorescent protein, we performed Western blot
analyses with lysates prepared from pMigR-Hd-BAZF and
pMigR-ATG-BAZF expressing cells, as well as from pMigR-
Hd-AES and pMigR-ATG-AES expressing cells. BAZF and
AES are two proteins of different molecular weights and
structures, both tagged with the same HA epitope. Their
expression thus reflects LTR promoter activities, while
eGFP expression is a reflection of IRES activities. As can be
seen in Fig 1, while the signals corresponding to the pro-
teins under the direct control of the LTR promoter remain
constant independent of the IRES present, the eGFP signal
is strikingly decreased in the case of the HindIII-modified
IRES.
Altogether, these experiments confirm that the integrity of
the initiating AUG of the EMCV IRES is absolutely
required for optimal activity, and that the modification
brought by the creation of a HindIII site results in a severe
loss of protein expression. It thus appears that when a
high expression of the IRES-controlled cistron is needed,
one should verify the integrity of the EMCV IRES present
in the expression vector used, and shift to a vector con-
























Sites present in the polylinker, 5' to 3', are indicated in bold type. 
Compatible sites are shown on the right.
*: only when "MK" from AccI GTMKAC site is CG (K = G or T, M = A 
or C).
**: prototype site with distinct cleavage structure.
Western blot analysis of HEK 293T cell lysatesFigure 1
Western blot analysis of HEK 293T cell lysates. Cells 
were transfected with pMigR-Hd and pMigR-ATG (Control), 
or pMigR-Hd-BAZF and pMigR-ATG -BAZF (BAZF), or 
pMigR-Hd-AES and pMigR-ATG-AES (AES). Hd: pMigR-Hd 
based vectors, ATG: pMigR-ATG based vectors. GFP, BAZF 
and AES: translation products of the corresponding cDNAs. 
Molecular weight markers are indicated.
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Engineering of a new and convenient retroviral IRES- 
containing vector, pPRIG
In order to palliate the problems stemming from the use
of HindIII-modified IRES-containing expression vectors,
we set up to develop a new vector that would permit i)
easy directional cloning and sequencing of most inserts;
ii) possible HA-tagging of the expressed proteins; iii) easy
detection of the transduced cells through high expression
Structure of the four pPRIG vector polylinkersFigure 2
Structure of the four pPRIG vector polylinkers. pPRIG is the prototype polylinker, while the three pPRIG-HA vectors 
contain additional 1-nucleotide frame-shifted coding sequences for HA-tagging 5' of the polylinker sequence. Any insert can 
thus be cloned either in-frame downstream of this HA-tag, or directly into the pPRIG, without the HA-tag.
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of the IRES-controlled eGFPand iv) production of retrovi-
ral particles if needed. We called this new vector series
pPRIG, for plasmid Polylinker Retroviral IRES GFP.
Bidirectional polylinker design
We designed a new polylinker which allows for the bidi-
rectional cloning of a wide range of fragments. We used a
strategy in which any site localized on one side of the
polylinker has a matching counterpart on the other
extremity. Altogether, our polylinker contains 20 unique
restriction sites, including 15 sites allowing bidirectional
cloning (Table 2). For example, an EcoRI/NotI DNA frag-
ment can be inserted directly in the polylinker either by
opening it with EcoRI and NotI, or in the reverse orienta-
tion by digesting the polylinker with NotI and MfeI,
which is compatible with EcoRI. Our design permits the
bidirectional cloning of up to 54 distinct site combina-
tions, compared to, for example, the pBSK linker family
which allows for only 7 such bidirectional clonings
through the NotI/Bsp120I compatible sites. To our
knowledge, our polylinker structure is the first one pro-
posed with such a high number of possible bidirectional
clonings.
N-terminal HA-tagging
The pPRIG vector is designed to allow the fusion of an
HA-tag in the N-terminal part of the protein of interest if
needed. This way, the translation product of the cloned
insert can be monitored through immunological
approaches (immunolocalization, ELISA, Western blot-
ting, immunoprecipitation...). To facilitate in phase-clon-
ing, 3 versions have been developed (pPRIG-HA1, 2 and
3, see Fig. 2), each with a one nucleotide shift upstream of
the stretch coding for the classical HA-tag. Thus, depend-
ing upon the reading frame of the insert of interest, either
pPRIG-HA1, pPRIG-HA2 or pPRIG-HA3 can be used. Fig.
2 illustrates the 4 different polylinker structures available
in the pPRIG vector family.
Direct sequencing with T7 and SP6primers
Flanking of the polylinker with T7 and SP6 universal
primer sites makes sequencing of any insert straightfor-
ward. Our vectors are simultaneously cloning, expression
and proviral vectors therefore no additional subcloning
into other vectors is required. Sequencing of the insert of
interest with T7 and SP6 primers allows for the verifica-
tion of the integrity of the insert as well as the coherence
of the coding frame following in vitro transcription/trans-
lation. Amplification of the plasmid is all that is needed to
obtain material for functional assays in cells. The back-
bone of the vectors is derived from the pUC vector series,
which insures a high DNA yield during plasmid amplifi-
cation. We routinely obtained production of at least 5 mg/
l of culture medium (LB-50 µg/ml Ampicillin) with all of
our constructs, reaching up to 20 mg/l with some, as well
as with the empty vectors. The production differences
Schematic representation of the pPRIG-HA-Red and pPRIG-Hd-HA-Red retroviral vectorsFigure 3
Schematic representation of the pPRIG-HA-Red and pPRIG-Hd-HA-Red retroviral vectors. Top drawing illus-
trates pPRIG-HA-Red, in which the coding sequence of DsRed has been cloned in the polylinker, while pPRIG-Hd-HA-Red is 
the same exact construct except that the IRES initiation codon is modified into a HindIII site (see Table 1). The psi letter (Ψ) is 
the MLV encapsidation sequence, the CMV promoter drives the expression of the bicistronic RNA, the hatched boxes flanking 
DsRed correspond to the polylinker, encompassing the T7 and SP6 sequences and the HA coding sequence, the IRES corre-
sponds to the EMCV-derived IRES fragment, eGFP is the coding sequence for green fluorescent protein used to track the first 
cistron expression, and the LTR corresponds to the MLV long terminal repeat. The hatched line symbolizes Puc-derived plas-
mid backbone.
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observed are likely to reflect the impact of the cloned
inserts on plasmid amplification.
Retroviral backbone
Transfection efficiency remains one of the most severe
limitations in the functional analysis of exogenously
expressed cDNAs. This is why we chose to build the pPRIG
vector on a retroviral backbone, which allows for the pro-
duction of viral particles when needed, in order to obtain
a high percentage of expressing cells. As a starting back-
bone for our pPRIG constructs, we used the pAP2 con-
struct, which was kindly provided to us by Dr. J. Galipeau
[5]. This construct contains a CMV promoter, which effi-
ciently drives the expression of the bicistronic RNA fol-
lowing transfection in cells and which is replaced by an
LTR when used in a retroviral context, due to the 3' LTR
duplication upon reverse transcription.
Since it is important to monitor the percentage of the pop-
ulation actually expressing the vector following transfec-
tion or transduction, we inserted the eGFP coding
sequence downstream of the IRES. We then confirmed
that the large difference in IRES dependent-eGFP expres-
sion detected by FACS and Western analyses using the
pMigR constructs remains true with the pPRIG vector. To
that end, we reintroduced a HindIII-modified IRES in the
pPRIG vector, and cloned DsRed, which codes for a red
fluorescent protein (RFP), under the direct control of the
CMV promoter, creating the pPRIG-Hd-HA-Red. We also
constructed the equivalent wt IRES-containing plasmid:
pPRIG-HA-Red. The schematic representation of these
vectors is depicted on Fig 3. The red and green fluores-
cences were followed under the microscope (Fig. 4).
While the first cistron activity, reflected by the RFP signal,
remains similar in both the wild type and the HindIII-
modified IRES containing constructs, the eGFP signal was
again strongly diminished when the IRES was modified by
the insertion of the HindIII site. The relatively weak signal
observed for DsRed is inherent to the weaker fluorescence
of DsRed as compared to eGFP.
Transduction assay
We cotransfected 293T cells with pPRIG-HA-Red and pro-
viral helper vectors to produce retroviral particles. The
viral supernatant was then used to transduce exponen-
tially growing primary rat fibroblasts (REF), and fluores-
cence was observed two weeks post transduction. A
parallel experiment was performed with the pAP2-HA-
Red, as well as with the pPRIG-Hd-HA-Red, and expres-
sion from each LTR (reflected by the HA-Red signals) was
Comparison of stable pPRIG-HA-Red, pPRIG-Hd-HA-Red and pAP2-HA-Red expressionsFigure 5
Comparison of stable pPRIG-HA-Red, pPRIG-Hd-
HA-Red and pAP2-HA-Red expressions. HEK 293T 
cells were cotransfected with each vector and helper con-
structs. Viral supernatants were collected after 2 days and 
applied to primary rat embryo fibroblasts. The REF cells 
were photographed two weeks post-transduction. Vis: phase 
contrast image. Exposure time was the same for the three 
GFP images, as well as for the three RFP images. Fluores-
cence intensities are thus a direct reflection of protein 
expression levels.
Comparison of transient pPRIG-HA-Red and pPRIGw-HA-Red expressi nsFigure 4
Comparison of transient pPRIG-HA-Red and 
pPRIGw-HA-Red expressions. HEK 293T cells were 
transfected with each vector, and the cells were photo-
graphed 48 h later. Vis: phase contrast image. Exposure time 
is the same for the two GFP images, and for the two RFP 
images. Fluorescence signals are thus a direct reflection of 
protein expression levels.
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compared with the expression stemming from the differ-
ent IRESes (reflected by the eGFP signals). First, we com-
pared the viral titers obtained with the three constructs. To
that end, serial dilutions of the supernatants were used to
transduce REF. Monitoring of the fluorescence in trans-
duced cells indicated a titer in the range of 1 × 106 per ml
for all three vectors (data not shown), indicating that the
polylinker and/or the modification of the IRES does not
affect viral activity. Second, we observed that HA-Red
expression was similar among the three vectors, indicating
that the IRESes and/or polylinkers did not affect the
expression driven by the LTR (Fig. 5). Third, and in good
agreement with the results obtained in our transient HEK
293T transfections, IRES-dependent eGFP expression
from the pPRIG vector was much more efficient than from
pAP2 or pPRIG-Hd, as illustrated in Fig. 5. The differences
in fluorescence were then monitored by Western analysis.
Lysates from cells expressing these constructs were loaded
in duplicate and run by SDS-PAGE, then subjected to
either an anti-GFP antibody or an anti-HA antibody. Strik-
ingly, we could barely detect the eGFP signal in the pRIG-
Hd and pAP2 constructs, while the pPRIG displayed a
strong signal (Fig. 6). In contrast, the HA-Red signal was
comparable among the three vectors, indicating that the
first cistron is similarly expressed in all three constructs,
whereas expression of the second cistron is highly
dependent upon the IRES integrity
Discussion
Extensive research over the last 15 years has led to signifi-
cant advances in deciphering the molecular mechanisms
involved in IRES function. All studies pointed to the
involvement of secondary structures in the recognition of
functional ribosome entry sites, as well as the importance
of the distance between the polypyrimidine track and the
actual initiating AUG. In the case of the Encephalomyo-
carditis virus-derived IRES, the second AUG located 22
nucleotides downstream of the UUUCC sequence,
present in the polypyrimidine-rich track at the 3' of the
IRES, has been identified as the authentic viral initiation
codon [3,4,7]. Some reports indicated that insertion of a
spacer up to 95 nucleotides between the 3' end of the IRES
and the ORF of interest was not deleterious to the second
cistron expression, provided that no secondary structure
or out of frame initiation codon were present within that
spacer [8]. Several constructs have been subsequently
developed in which the original AUG (gat gat aat ATG gcc
aca) was modified to a HindIII site (gat gat AAGCTT gcc
aca), with the idea that cloning of a cDNA in this HindIII
site would result in a further scanning of the ribosomes
down to the AUG found in the cloned cDNA where initi-
ation would occur. In this report we showed that despite
its popularity among scientists wishing to use an IRES-
containing expression vector, this modification present in
many commercial vectors actually results in a dramatic
decrease in the expression of the IRES-controlled coding
sequence as compared to that observed with the wild type
IRES. Earlier studies demonstrating that the EMCV IRES
possesses a scanning independent fixed location AUG [3],
together with the observations reported here, clearly sup-
port that the translational initiation is much more effi-
cient from the natural (non mutated) IRES than from a
HindIII mutated counterpart. This confirms that the IRES
and the initiation codon are not completely independent
modules that can be freely separated and remixed with
heterologous sequences, as is often done. In our studies,
we used the eGFP sequence as a reporter, whose initiator
AUG is located 12 bases downstream of the engineered
HindIII site (Table 1). Such a short distance is nevertheless
sufficient to greatly affect the eGFP expression, despite the
conservation of the optimal eGFP AUG context (acc AUG
gug). Indeed, FACS analyses indicated a more than 10 fold
difference in eGFP peak intensity. In addition, Western
blot analysis of eGFP expression following viral transduc-
tion using HindIII-modified vectors displayed a weak
eGFP signal, whereas wild type IRES resulted in a strong
eGFP signal. As a control, both wild type and HindIII-
modified constructs expressed HA-DsRed protein inde-
pendent of the different IRESes, and comparable amounts
of HA-DsRed were detected by Western blot analysis. In
view of these results, we constructed a new vector family
that allows for a wide range of applications, while keeping
a strong IRES-dependent expression. This vector series has
Comparison of the pPRIG-HA-Red (pPRIG), pPRIG-Hd-HA-Red ( PRIG-Hd) and pAP2-HA-Red (pAP2) GFP and RFP protein expression by Western blot analysisFigure 6
Comparison of the pPRIG-HA-Red (pPRIG), pPRIG-
Hd-HA-Red (pPRIG-Hd) and pAP2-HA-Red (pAP2) 
GFP and RFP protein expression by Western blot 
analysis. Equivalent amounts of cell lysates containing the 
eGFP and HA-DsRed expressed from the indicated vectors 
were loaded in duplicate, ran on SDS-PAGE, and analyzed 
with an anti GFP serum (left panel) and an anti-HA serum 
(right panel).
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been called pPRIG, for plasmid Polylinker Retroviral
IRESGFP. Due to a newly designed type of polylinker,
directional cloning of a wide range of inserts is greatly
facilitated, and HA-tagging of the insert of interest is pos-
sible if needed, depending upon which pPRIG vector is
selected. Furthermore, the presence of T7 and SP6 primer
sequences renders the sequencing of the cloned inserts
straightforward, while allowing for the verification of
insert expression via in vitro transcription/translation.
Finally, our vectors are built on a retroviral backbone,
allowing highly efficient cell transduction if needed. These
vectors will be made freely available to the scientific com-
munity upon request.
Conclusion
A survey of commonly used EMCV IRES-derived bicis-
tronic vectors indicated that many of them, including sev-
eral commercial ones, have their 11th AUG modified to a
HindIII site. In this work we confirm previous results
demonstrating that the EMCV IRES predominant AUG
(11th) cannot be modified without strongly affecting the
overall efficiency of the IRES-dependent expression. Con-
sequently, we show that all HindIII modified bicistronic
vectors are very ineffective for their IRES-dependent
expression. We developed a new family of expression vec-
tors, called pPRIG, in which the structure of the EMCV
IRES is left untouched. We verified that the IRES-depend-
ent eGFP expression is much stronger than the HindIII
modified IRES, and remains strong for weeks, even in a
retroviral context. The pPRIG also contains a new type of
polylinker that allows bidirectional cloning. In addition,
this vector family permits easy HA-tagging, sequencing
and in vitro expression of the insert, as well as the produc-
tion of retroviral particles if needed.
Methods
Constructs
All constructs were made using classical molecular biol-
ogy techniques, as described in [9]. A detailed construct
strategy is available upon request, but briefly, the four
pPRIG vectors were constructed as follows. The pPRIG-
Hd-HA vectors were constructed from the pAP2-IRE-
SeGFP, provided by Dr. J. Galipeau [5]. The EcoRI, NotI,
PvuII, SalI, SphI, SseI restriction sites were removed from
the vector in order to include them in a newly developed
Multiple Cloning Site (MCS). A sequence encompassing a
T7 bacterial promoter and an HA tag (followed by BamHI
and EcoRI sites) was inserted between the end of delta-gag
and the beginning of the IRES. Double stranded oligonu-
cleotides containing the MCS were inserted between the
BamHI and EcoRI sites. Three sets of oligonucleotides
were used to create the three HA tags, each one being in a
different frame as compared to the MCS, giving rise to
pPRIG-Hind-HA 1, 2 and 3. The pPRIG-Hd was obtained
by deleting the HA tag sequence after digestion with
NgoAIV and BamHI, filling in with the Klenow polymer-
ase and religation (the BamHI site is recovered in this
process). All vectors from the pPRIG series are identical to
the pPRIG-Hd vectors, except for the presence of the wild
type EMCV IRES initiation codon in place of the HindIII
site.
The pMigR vector [6] is similar to the pAP2-IRESeGFP yet
differs in the following manner. The CMV promoter is
replaced by an LTR. There are a few punctual differences
in sequences in the LTRs as compared to the pAP2-IRE-
SeGFP 3' LTR. The IRES sequence has conserved the 3' ini-
tiating AUG, which is mutated in the pAP2-IRESeGFP
vector to generate a HindIII site. The eGFP polypeptide
starts with its own AUG in the pAP2-IRESeGFP vector,
while it is in frame with the IRES 3' AUG in the pMigR vec-
tor.
The pMigR-Hd, containing the pPRIG-Hd-HA-MCS and
IRES (ATG mutated to generate a HindIII), was obtained
by replacing the SpeI-NcoI fragment of the pMigR vector
by the corresponding one from the pPRIG-Hd-HA. The
pMigR-ATG, containing the pPRIG-Hd-HA MCS and the
pMigR IRES (wt EMCV sequence retaining the 3' IRES
ATG), was obtained by replacing the SpeI-DraIII of the
pMigR by the corresponding SpeI/DraIII fragment from
the pPRIG-HA vectors.
The EcoRI/Bsp120 I fragment of the pcDNA-BAZF vector
encoding the mouse BAZF cDNA [10] was cloned at the
EcoRI/NotI sites of the MigR-pAP7 HinDIII and MigR-
pAP7 ATG vectors. The mouse AES (also known as GRG5)
cDNA [11] containing the entire open reading frame was
synthetized by PCR using retrotranscribed GS2 embryonic
stem cell mRNA as templates. The PCR product (a gift
from Dr D. Sekkaï) containing a 5' Xho I and a 3' EcoRI
site brought by the primers, was cloned into the pDrive
vector (Qiagen), verified by sequencing, and then cloned
into the Xho I/Mfe I sites of the MigR-pAP7 HinDIII and
MigR-pAP7-ATG vectors.
pPRIG-Hd-HA-Red, pPRIG-HA-Red and pAP2-HA-Red
were obtained as follows. For, pPRIG-Hd-HA-Red and
pPRIG-HA-Red, the BamHI-NotI fragment from pDsRED-
N1 was cloned into pRIG-Hd-HA2 and pPRIG-HA2,
respectively, digested with the same restriction enzymes.
For pAP2-HA-Red, the NgoAIV-AccI fragment from pRIG-
HA-Red was cloned into BBg (a derivative of pBluescript
SKII containing a BglII site) digested with XmaI-AccI to
give the BBg HA-Red from which the BglII -XhoI fragment
(coding for the HA-DsRed fusion polypeptide) was puri-
fied and recloned into the pAP2-IRESeGFP vector opened
by BglII and XhoI.
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Transfections/transduction
HEK 293T cells were grown in DMEM supplemented with
10% FCS. Cells were seeded at 30–40% confluence in 6
well plates (about 500 000 cells/well), and transfected the
following day with 1.6 µg of the different expression vec-
tors. Cells were analyzed between 24 and 72 h post-trans-
fection. For virus production, the different expression
vectors were cotransfected with 0.8 µg of pCMV-GagPol
and 0.8 µg of pCMV-VSVG helper plasmids. Supernatants
were collected 48 h post-transfection, passed through 0.45µm filters, then added to the exponentially growing REF
cultures in the presence of 4 µg/ml of polybrene. The
medium was changed 16 h later, and transduced cells
were kept in culture and passed 3× every 4 days.
Western-blots
Cells were harvested, lysed and boiled in Laemmli buffer.
1/20 of each lysate was loaded and migrated by SDS-
PAGE, and analysed by Western blotting. The membranes
were incubated with F-7 mouse anti-HA antibody (1/500,
Santa Cruz) and with rabbit A.v. peptide anti-GFP anti-
body (1/200, Clontech), followed by a peroxydase-cou-
pled anti-mouse or anti-rabbit antibody, respectively. The
signals were revealed by chemiluminescence.
FACS analysis
48 h post- transfection, HEK 293T cells were rinsed and
harvested in PBS, then analysed for GFP expression by
flow cytometry using a Facscan (Becton Dickinson).
10000 events were recorded.
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